The U.S. Food and Drug Administration is moving toward allowing compounding pharmacies to produce more than a dozen injectable peptides that were banned because of potentially significant safety risks, the New York BPC 157 Rapid 250mcg Pure Prescriptions Injectable Peptides: Out of the Back Alley and Into the Light? Berkley Lifesciences The FDA has issued clear signals on BPC 157: it is not approved for human use in any form due to potential significant safety risks. This critical classification profoundly impacts research and The Human Lab Rats Injecting Themselves with Peptides Office for Science and Society McGill University